Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 3Sarcoma 2Thoracic 1Head & Neck 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Sarcoma 63Osteosarcoma 16Leiomyosarcoma 16Neoplasm Metastasis 10Pancreatic Neoplasms 9Breast Neoplasms 9Bone Neoplasms 8Rhabdomyosarcoma 6Ovarian Neoplasms 6Neoplasms 6Colorectal Neoplasms 6Small Cell Lung Carcinoma 5Sarcoma, Ewing 5Liposarcoma 5Head and Neck Neoplasms 5Colonic Neoplasms 5Sarcoma, Synovial 4Prostatic Neoplasms 4Melanoma 4Histiocytoma, Malignant Fibrous 4Hemangiosarcoma 4Chondrosarcoma 4Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Recurrence 3Lymphoma, Non-Hodgkin 3Lung Neoplasms 3Gastrointestinal Stromal Tumors 3Esophageal Neoplasms 3Dermatofibrosarcoma 3

Interventions

Paclitaxel 2Gemcitabine 2seribantumab 1pembrolizumab 1cemiplimab 1camrelizumab 1apatinib 1Radionuclide Imaging 1Quality of Life 1Patient Reported Outcome Measures 1OSI 930 1Nivolumab 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Letrozole 1Immunotherapy 1Immune Checkpoint Inhibitors 1Fluorodeoxyglucose F18 1FAPI-46 1FANG vaccine 1Drug Therapy 1Doxorubicin 1Docetaxel 1Cisplatin 1Carboplatin 1Bortezomib 1Biological Therapy 1Axitinib 14-hydroxy-N-desmethyltamoxifen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Uterine Neoplasms × Gemcitabine × Sarcoma × Clear all
NCT00620295 2017-11-29

Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Completed
17 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Uterine Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT00282087 2014-12-01

Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma

Sarcoma Alliance for Research through Collaboration

Phase 2 Completed
47 enrolled 16 charts
GynecologicSarcoma

Leiomyosarcoma, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡